)

Spin off

Imagen subrayado titulo
  • Aligen Therapeutics.
    Company focused on cardiovascular diseases

    Aligen Therapeutics is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Aligen holds licenses of CIMA’s patents and know-how on cardiovascular research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.

    TEASER: "New antihemorrhagic agents: a novel antifibrinolytic strategy"


    Contact:
    Jesús Hernández, Sole Administrator.

    Julen Oyarzabal, CIMA, Translational Sciences Director.
    Business Development Unit: bdcima@unav.es

  • Epical Biosciences.
    Company focused on cancer research

    Epical Biosciences is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Epical Biosciences holds licenses of CIMA’s patents and know-how on cancer research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.

    TEASER: "New epigenetic agents: therapeutic approach in cancer"


    Contact:
    Jesús Hernández, Sole Administrator.
    Julen Oyarzabal, CIMA, Translational Sciences Director.
    Business Development Unit: bdcima@unav.es

Business development

Contacto:
Centro de Investigación Médica Aplicada (CIMA)
Avenida Pío XII, 55
31008 Pamplona
España

+34 948 194 700
bdcima@unav.es

Aviso

Esta web utiliza cookies propias y de terceros para mejorar tu experiencia de usuario y mostrarte contenido relacionado con tus preferencias. Si continúas navegando, consideramos que aceptas su uso.

Aceptar